Contrasting Careview Communications (OTCMKTS:CRVW) & Tempus AI (NASDAQ:TEM)

Careview Communications (OTCMKTS:CRVWGet Free Report) and Tempus AI (NASDAQ:TEMGet Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares Careview Communications and Tempus AI’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Careview Communications -55.51% N/A -110.03%
Tempus AI -88.27% -533.21% -66.19%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Careview Communications and Tempus AI, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Careview Communications 0 0 0 0 0.00
Tempus AI 0 6 6 0 2.50

Tempus AI has a consensus target price of $65.0909, indicating a potential upside of 6.93%. Given Tempus AI’s stronger consensus rating and higher probable upside, analysts clearly believe Tempus AI is more favorable than Careview Communications.

Institutional & Insider Ownership

24.2% of Tempus AI shares are held by institutional investors. 63.9% of Careview Communications shares are held by company insiders. Comparatively, 27.6% of Tempus AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Careview Communications has a beta of -0.21, meaning that its stock price is 121% less volatile than the S&P 500. Comparatively, Tempus AI has a beta of 4.98, meaning that its stock price is 398% more volatile than the S&P 500.

Earnings and Valuation

This table compares Careview Communications and Tempus AI”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Careview Communications $8.25 million N/A -$4.70 million N/A N/A
Tempus AI $693.40 million 15.20 -$705.81 million ($7.80) -7.80

Careview Communications has higher earnings, but lower revenue than Tempus AI.

Summary

Tempus AI beats Careview Communications on 7 of the 11 factors compared between the two stocks.

About Careview Communications

(Get Free Report)

CareView Communications, Inc. provides video monitoring solutions in the United States. Its products include CareView Patient Safety System, a video monitoring tool to improve the practice of nursing, create a better work environment, and make the patient's hospital stay more satisfying, which is used in hospitals, nursing homes, adult living centers, and outpatient care facilities; and CareView Connect, which provides resident monitoring products and services for the long- term care industry; an array of wearable and stationary buttons that allow a resident to summon help either for an emergency or assistance; a mobile app capable of delivering an alert to the caregiver and allows them document information around that alert; and alert management and monitoring system that provides a suite of hardware and software to facilitate a data-driven solution for alert management and monitoring. The company also offers Caregiver Platform that offers caregiver connect mobile application to provide a convenient and intuitive interface to capture critical workflows, such as acknowledging and documenting alert presses by the resident. In addition, it provides SitterView and TeleMedView that allows hospital staff to use CareView's video cameras to observe and communicate with patients remotely. CareView Communications, Inc. is based in Lewisville, Texas.

About Tempus AI

(Get Free Report)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Receive News & Ratings for Careview Communications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Careview Communications and related companies with MarketBeat.com's FREE daily email newsletter.